Events
Leads Biolabs Secures China Phase III Approval For Opamtistomig In First Line EP NEC Treatment
Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that its proprietary PD-L1/4-1BB bispecific antibod...
May 20, 2026 | News
Sino Biological Europe GmbH Launches EliteScience VIP Partnership Program For European Researchers
Sino Biological Europe GmbH, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently launched its El...
May 13, 2026 | News
Genexine Advances First In Class SOX2 Targeting BioPROTAC GX BP1 With Strong Preclinical Anti Tumour Data
Genexine, Inc. (KOSDAQ: 095700), a clinical-stage biotechnology company, announced new preclinical data for its SOX2-targeting bioPROTAC candidate, G...
May 04, 2026 | News
Akamis Bio Reports Promising Early Efficacy For NG 350A In Rectal Cancer Study
NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...
April 21, 2026 | News
EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study
First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...
April 21, 2026 | News
Synthetic Design Lab Introduces Logic Gated SYNTHBODY Platform Redefining Precision Protein Therapeutics
SYNTHBODY™ introduces a new class of “smart drugs”: protein therapeutics with built-in, multi-layered logic gates that actively chang...
April 20, 2026 | News
AnBogen Therapeutics Showcases Imofinostat Breakthroughs At AACR Annual Meeting 2026
AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, announced that two key research abstracts regarding its lead co...
April 14, 2026 | Report
Locus Cell And Charles River Sign Strategic MoU To Advance Cell And Gene Therapy Manufacturing In APAC
Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles Riv...
March 13, 2026 | News
Akeso Reports Durable Long Term Survival Benefit Of Cadonilimab In Advanced Cervical Cancer
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II ...
March 06, 2026 | Report
Blueprint Medicines Showcases Four Year AYVAKIT Data Reinforcing Durable Benefit In Indolent Systemic Mastocytosis
-- Real-world study of AYVAKIT highlights improvement across ISM symptoms -- -- 12 data presentations at 2026 AAAAI Annual Meeting reflect company's ...
March 02, 2026 | Report
CaseBioscience Launches Cell Therapy Grade Cryopreservation And Hypothermic Storage Solutions At Advanced Therapies Week 2026
Introducing cell therapy–grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performa...
February 10, 2026 | News
Kelun Biotech Wins China Approval For Sacituzumab Tirumotecan In Advanced Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-dir...
February 09, 2026 | News
ACROBiosystems Deepens Global Partnering Engagement At BIOSeedin Winter Innovation Summit Ahead Of J P Morgan 2026
On January 11, as the global healthcare industry gathered in San Francisco, the BIOSeedin Winter Innovation Partnering Summit successfully conven...
February 04, 2026 | News
Turning Frontline Reality Into Policy Action For Cancer Care In Asia
Drawing on her frontline clinical experience in Malaysia, Prof Dr Wan Zamaniah, Consultant Clinical Oncologist, University Malaya Medical Centre&...
February 02, 2026 | Expert Insight
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
